<DOC>
	<DOCNO>NCT00509639</DOCNO>
	<brief_summary>The purpose study compare change Perianal Crohn 's Disease follow use locally apply 10 % metronidazole ointment placebo .</brief_summary>
	<brief_title>Evaluation Topical 10 % Metronidazole Ointment Treatment Active Perianal Crohn 's Disease</brief_title>
	<detailed_description>Anorectal Crohn 's disease one problematic debilitate condition encounter colorectal practise . The condition usually chronic , debilitating , frequently refractory current medication . Failure respond medical therapy may ultimately result proctocolectomy ileostomy , even absence proximal colonic disease . Isolated anorectal Crohn 's disease report 3 5 % Crohn 's patient . In Crohn 's patient whole , anorectal involvement report one third one half patient , addition either colonic enteric Crohn 's disease . In spite previously report painless nature anorectal Crohn 's disease , author 's experience condition inordinately painful due deeply erode fissure , oedematous skin tag , painful induration perianal region .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Have Crohn 's disease ( diagnosed radiology , endoscopy pathology ) , anorectal involvement . Have perianal symptom longer 3 month Have PCDAI 5 baseline Subjects concomitant medication . Acceptable regime : Aminosalicylates dosage stable 4 week screen ; Oral corticosteroid &lt; 40mg per day stable 3 week ; Methotrexate give least 3 month stable 4 week ; Azathioprine mercaptopurine give least 6 month dosage stable 8 week ; Antibiotics dosage stable 4 week ( subject may oral metronidazole dose 750mg per day ) , Cycolsporin 3 month stable dose 4 week ; Patients treat Infliximab must receive initial dose 3 month start study medication recent dose least 8 week start study medication receive infusion whilst doubleblind treatment phase study 4 week . During second 4 week open stage study patient commence maintenance regime Infliximab treatment deem necessary Any patient concurrent medication must medication least 4 week screen . If patient Setons must place least 4 week prior screen . Subjects must age 18 year legal age consent . If female , subject must lactate must ( ) post menopausal , ( b ) surgically sterilise , ( c ) negative pregnancy test result prior entry study use double barrier method contraception ( two separate method birthcontrol one may include oral contraception ) duration study . Must provide write informed consent participate . They surgery anus rectum past 4 week ; They perianal abscess require incision drainage ; They stoma less 6 month duration ; Allergic metronidazole ; Are take prohibited medication . Deemed mentally incompetent . Considered physician unlikely able comply protocol . Taken part experimental drug study precede three month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>